HealthEquity, Inc.

NasdaqGS:HQY Voorraadrapport

Marktkapitalisatie: US$9.1b

HealthEquity Beheer

Beheer criteriumcontroles 3/4

De CEO HealthEquity is Jon Kessler, benoemd in Feb2014, heeft een ambtstermijn van 10.75 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 13.45M, bestaande uit 5.2% salaris en 94.8% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.35% van de aandelen van het bedrijf, ter waarde $ 31.87M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3 jaar en 7.7 jaar.

Belangrijke informatie

Jon Kessler

Algemeen directeur

US$13.4m

Totale compensatie

Percentage CEO-salaris5.2%
Dienstverband CEO10.8yrs
Eigendom CEO0.4%
Management gemiddelde ambtstermijn3yrs
Gemiddelde ambtstermijn bestuur7.7yrs

Recente managementupdates

Recent updates

HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 41% Below Their Intrinsic Value Estimate

Nov 20
HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 41% Below Their Intrinsic Value Estimate

HealthEquity: High Marks For Recent Profit Growth

Nov 20

We Think HealthEquity (NASDAQ:HQY) Can Stay On Top Of Its Debt

Oct 31
We Think HealthEquity (NASDAQ:HQY) Can Stay On Top Of Its Debt

Getting In Cheap On HealthEquity, Inc. (NASDAQ:HQY) Might Be Difficult

Aug 30
Getting In Cheap On HealthEquity, Inc. (NASDAQ:HQY) Might Be Difficult

HealthEquity: Compelling Catalysts, Fairly Valued, Reiterate Buy

Aug 27

Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Jul 13
Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation

Jun 21
We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation

Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jun 07
Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

HealthEquity: A Trading Vehicle Performing As Expected, Strong Growth Hard To Ignore

Jun 04

HealthEquity: Strong Growth And Healthy Cash Flows Changed My Mind

May 29

Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?

May 03
Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?

Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues

Apr 11
Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues

HealthEquity: Multiple Compression Has Finally Made It A Buy

Mar 21

Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects

Dec 28
Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects

Is HealthEquity (NASDAQ:HQY) A Risky Investment?

Nov 17
Is HealthEquity (NASDAQ:HQY) A Risky Investment?

HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price

Oct 26
HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price

Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Jul 27
Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jul 07
HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate

Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Apr 18
Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Mar 14
Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Dec 24
Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Dec 02
Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 11
Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Sep 08
These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M

Sep 06

HealthEquity: Asymmetry In Valuation Continues To Widen

Aug 25

HealthEquity COO steps down, CEO to assume his responsibilities

Aug 02

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Jul 27
Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Jul 06
Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

May 24
These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Analyse CEO-vergoeding

Hoe is Jon Kessler's beloning veranderd ten opzichte van HealthEquity's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jul 31 2024n/an/a

US$106m

Apr 30 2024n/an/a

US$80m

Jan 31 2024US$13mUS$700k

US$56m

Oct 31 2023n/an/a

US$29m

Jul 31 2023n/an/a

US$13m

Apr 30 2023n/an/a

-US$8m

Jan 31 2023US$13mUS$700k

-US$26m

Oct 31 2022n/an/a

-US$59m

Jul 31 2022n/an/a

-US$62m

Apr 30 2022n/an/a

-US$55m

Jan 31 2022US$10mUS$700k

-US$44m

Oct 31 2021n/an/a

-US$6m

Jul 31 2021n/an/a

US$723k

Apr 30 2021n/an/a

US$4m

Jan 31 2021US$9mUS$667k

US$9m

Oct 31 2020n/an/a

US$3m

Jul 31 2020n/an/a

-US$20m

Apr 30 2020n/an/a

-US$332k

Jan 31 2020US$5mUS$500k

US$40m

Oct 31 2019n/an/a

US$53m

Jul 31 2019n/an/a

US$90m

Apr 30 2019n/an/a

US$93m

Jan 31 2019US$5mUS$483k

US$74m

Oct 31 2018n/an/a

US$67m

Jul 31 2018n/an/a

US$61m

Apr 30 2018n/an/a

US$56m

Jan 31 2018US$4mUS$400k

US$47m

Compensatie versus markt: De totale vergoeding ($USD 13.45M ) Jon } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 7.74M ).

Compensatie versus inkomsten: De vergoeding van Jon is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Jon Kessler (56 yo)

10.8yrs

Tenure

US$13,448,018

Compensatie

Mr. Jon Kessler is a Member of the Board of Managers at HealthEquity Advisors, LLC. He has been the Chief Executive Officer and President of HealthEquity, Inc. since February 2014. Mr. Kessler founded Wage...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Jon Kessler
President10.8yrsUS$13.45m0.35%
$ 31.9m
Stephen Neeleman
Founder & Vice Chairman22yrsUS$3.04m0.94%
$ 85.4m
James Lucania
CFO & Executive VP1.2yrsUS$5.23m0.0086%
$ 784.7k
Elimelech Rosner
Executive VP & CTO2.7yrsUS$4.81m0.0033%
$ 298.6k
Delano Ladd
Executive VP8.2yrsUS$2.64m0.044%
$ 4.0m
Richard Putnam
Vice President of Investor Relationsno datageen gegevensgeen gegevens
Steve Lindsay
Executive Vice President of Sales & Relationship Management3.3yrsgeen gegevensgeen gegevens
Brad Bennion
Executive Vice President of Corporate Development & Strategy7.6yrsgeen gegevensgeen gegevens
Tia Padia
Executive VP & Chief Marketing Officer2.8yrsgeen gegevensgeen gegevens
Cheryl King
Executive VP & Chief People Officer1.6yrsgeen gegevensgeen gegevens
Kamesh Tumsi
Senior VP & Head of Product2yrsgeen gegevensgeen gegevens
Selim Aissi
Executive VP & Chief Security Officerno datageen gegevensgeen gegevens

3.0yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van HQY wordt beschouwd als ervaren (gemiddelde ambtstermijn 3 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Jon Kessler
President15.7yrsUS$13.45m0.35%
$ 31.9m
Stephen Neeleman
Founder & Vice Chairman22yrsUS$3.04m0.94%
$ 85.4m
Adrian Dillon
Independent Director8.2yrsUS$297.50k0.062%
$ 5.7m
Robert Selander
Independent Non-Executive Chairman9.2yrsUS$362.50k0.065%
$ 6.0m
Paul Black
Independent Director2.2yrsUS$272.50k0.0050%
$ 457.9k
Evelyn Dilsaver
Independent Director10.3yrsUS$290.00k0.037%
$ 3.3m
Stuart Parker
Independent Director3.9yrsUS$280.00k0.035%
$ 3.2m
Gayle Wellborn
Independent Director7.3yrsUS$278.87k0.017%
$ 1.6m
Debra McCowan
Independent Director6.6yrsUS$275.00k0.012%
$ 1.1m
Rajesh Natarajan
Independent Director2.5yrsUS$272.50k0.0096%
$ 875.8k

7.7yrs

Gemiddelde duur

62.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van HQY wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.7 jaar).